Integrating phenotypic small-molecule profiling and human genetics: The next phase in drug discovery
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
PubMed ID
25498789
Metadata
Show full item recordURI
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84920683698&origin=inward; http://hdl.handle.net/2384/582902DOI
10.1016/j.tig.2014.11.002ae974a485f413a2113503eed53cd6c53
10.1016/j.tig.2014.11.002
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- Applications of chemogenomic library screening in drug discovery.
- Authors: Jones LH, Bunnage ME
- Issue date: 2017 Apr
- GPCR profiling: from hits to leads and from genotype to phenotype.
- Authors: Cvijic ME, Sum CS, Alt A, Zhang L
- Issue date: 2015 Nov
- Connecting synthetic chemistry decisions to cell and genome biology using small-molecule phenotypic profiling.
- Authors: Wagner BK, Clemons PA
- Issue date: 2009 Dec
- Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitors.
- Authors: Liao D
- Issue date: 2015 Nov
- Identification and validation of bioactive small molecule target through phenotypic screening.
- Authors: Cho YS, Kwon HJ
- Issue date: 2012 Mar 15